Neuropeptide FF Promotes Neuronal Survival and Enhances Synaptic Protein Expression Following Ischemic Injury.

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Ischemic stroke causes significant neuronal damage and loss.
• Neuropeptide FF (NPFF) has been implicated in various neurological processes.
• Understanding NPFF's role in neuroprotection is crucial for developing stroke therapies.

Purpose of the Study:

• To investigate the neuroprotective effects of neuropeptide FF (NPFF) in ischemic injury.
• To explore the molecular mechanisms underlying NPFF's role in neuronal recovery.
• To evaluate NPFF as a potential therapeutic agent for stroke.

Main Methods:

• Transcriptomic analysis in stroke models.
• Treatment of primary cortical cultures with recombinant NPFF (rNPFF) under oxygen-glucose deprivation.
• Assessment of cellular damage using lactate dehydrogenase release.
• Evaluation of neuronal markers (TUJ1, MAP2) and synaptic proteins (GAP43, PSD95, synaptophysin) expression.
• Analysis of signaling pathways including BDNF, PKCε, Sirtuin 1, and PPARγ.

Main Results:

• rNPFF significantly reduced lactate dehydrogenase release, indicating decreased cellular damage.
• rNPFF increased the expression of neuronal survival markers TUJ1 and MAP2.
• rNPFF upregulated key synaptic proteins essential for repair and plasticity.
• rNPFF treatment boosted pro- and mature-brain-derived neurotrophic factor (BDNF) levels.
• rNPFF activated PKCε, Sirtuin 1, and PPARγ pathways, promoting cellular stress response and homeostasis.

Conclusions:

• Recombinant NPFF (rNPFF) demonstrates significant neuroprotective effects against ischemic injury.
• NPFF enhances neuronal survival, dendritic integrity, and synaptic plasticity.
• NPFF activates key signaling pathways involved in cellular recovery and homeostasis.
• NPFF shows considerable potential as a therapeutic target for stroke recovery.